Skip to main content
Advertisement

Main menu

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET

User menu

  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Pharmacology and Experimental Therapeutics
  • Other Publications
    • Drug Metabolism and Disposition
    • Journal of Pharmacology and Experimental Therapeutics
    • Molecular Pharmacology
    • Pharmacological Reviews
    • Pharmacology Research & Perspectives
    • ASPET
  • My alerts
  • Log in
  • My Cart
Journal of Pharmacology and Experimental Therapeutics

Advanced Search

  • Home
  • Articles
    • Current Issue
    • Fast Forward
    • Latest Articles
    • Archive
  • Information
    • Instructions to Authors
    • Submit a Manuscript
    • FAQs
    • For Subscribers
    • Terms & Conditions of Use
    • Permissions
  • Editorial Board
  • Alerts
    • Alerts
    • RSS Feeds
  • Virtual Issues
  • Feedback
  • Visit jpet on Facebook
  • Follow jpet on Twitter
  • Follow jpet on LinkedIn

Table of Contents

June 01, 1984; Volume 229,Issue 3
  • You have access
    Altered effects of desipramine on operant performance after 6-hydroxydopamine-induced depletion of brain dopamine or norepinephrine.
    J M O'Donnell and L S Seiden
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 629-635;
  • You have access
    Effects of methadone on human cigarette smoking and subjective ratings.
    L D Chait and R R Griffiths
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 636-640;
  • You have access
    Cerebral delta opioid receptors mediate analgesia but not the intestinal motility effects of intracerebroventricularly administered opioids.
    J J Galligan, H I Mosberg, R Hurst, V J Hruby and T F Burks
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 641-648;
  • You have access
    Correlation between lung and plasma angiotensin converting enzyme and the hypotensive effect of captopril in conscious rabbits.
    X Chen, B R Pitt, R Moalli and C N Gillis
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 649-653;
  • You have access
    Responses to leukotriene C4 in the perfused rat lung.
    V J Iacopino, S Compton, T Fitzpatrick, P Ramwell, J Rose and P Kot
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 654-657;
  • You have access
    Preferential effects of 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU) on pulmonary glutathione reductase and glutathione/glutathione disulfide ratios: possible implications for lung toxicity.
    A C Smith and M R Boyd
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 658-663;
  • You have access
    Increased renal tubular sodium pump and Na+,K+-adenosine triphosphatase in streptozotocin-diabetic rats.
    D D Ku and E Meezan
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 664-670;
  • You have access
    Effects of phencyclidine, amphetamine and related compounds on dopamine release from and uptake into striatal synaptosomes.
    J F Bowyer, K P Spuhler and N Weiner
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 671-680;
  • You have access
    Pharmacologic analysis of two novel inhibitors of leukotriene (slow reacting substance) release.
    J H Fleisch, K D Haisch, S M Spaethe, L E Rinkema, G J Cullinan, M J Schmidt and W S Marshall
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 681-689;
  • You have access
    Evaluation of calcium entry blockers in several models of immediate hypersensitivity.
    D M Ritchie, J N Sierchio, C M Bishop, C C Hedli, S L Levinson and R J Capetola
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 690-695;
  • You have access
    Nickel inhibition of calcium release from subsarcolemmal calcium stores of molluscan smooth muscle.
    Z Wang, C P Bianchi and S R Narayan
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 696-701;
  • You have access
    Imipramine-cimetidine interaction: impairment of clearance and enhanced absolute bioavailability.
    D R Abernethy, D J Greenblatt and R I Shader
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 702-705;
  • You have access
    Mouse locomotor activity: an in vivo test for dopamine autoreceptor activation.
    G E Martin and R J Bendesky
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 706-711;
  • You have access
    Pharmacological differentiation of postsynaptic alpha adrenoceptors in the dog saphenous vein.
    P J Fowler, M Grous, W Price and W D Matthews
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 712-718;
  • You have access
    Tissue distribution of prednisolone in the rabbit.
    N Khalafallah and W J Jusko
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 719-725;
  • You have access
    Membrane properties and aging: in vivo and in vitro effects of ethanol on synaptosomal gamma-aminobutyric acid (GABA) release.
    R Strong and W G Wood
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 726-730;
  • You have access
    Ethanol-induced locomotor stimulation in rats after thyrotropin-releasing hormone.
    G R Breese, S Coyle, A C Towle, R A Mueller, T J McCown and G D Frye
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 731-737;
  • You have access
    Effects of analogs of salicylate on p-aminohippurate uptake into basal-lateral membranous vesicles.
    S S Tse, C Bildstein, D Liu and R D Mamelok
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 738-746;
  • You have access
    Pharmacological differences between the high-affinity muscarinic agonist binding states of the rat heart and cerebral cortex labeled with (+)-[3H]cismethyldioxolane.
    T W Vickroy, W R Roeske and H I Yamamura
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 747-755;
  • You have access
    Effects of dopamine (DA) and SKF 82526, a selective DA1-receptor agonist, on vascular resistances in the canine forelimb.
    G J Grega, R J Barrett, S W Adamski and M F Lokhandwala
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 756-762;
  • You have access
    Isolated parietal cells: adrenergic response and pharmacology.
    G C Rosenfeld
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 763-767;
  • You have access
    Morphine-like discriminative stimulus effects of buprenorphine and demethoxybuprenorphine in rats: quantitative antagonism by naloxone.
    H E Shannon, E J Cone and C W Gorodetzky
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 768-774;
  • You have access
    L-646,462, a cyproheptadine-related antagonist of dopamine and serotonin with selectivity for peripheral systems.
    M Williams, G E Martin, D C Remy, M Hichens, A W Mangel, D A Taylor, G G Yarbrough, R J Bendesky, S W King and J L Robinson
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 775-781;
  • You have access
    Comparison of iprindole, imipramine and mianserin action on brain serotonergic and beta adrenergic receptors.
    O Gandolfi, M L Barbaccia and E Costa
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 782-786;
  • You have access
    Electrocardiographic analysis of the effects of isosorbide-5-mononitrate on regional myocardial ischemia in conscious dogs.
    K Strein, G Sponer, W Bartsch, B Müller-Beckmann and K Dietmann
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 787-792;
  • You have access
    Effects of 2-nicotinamidoethyl nitrate (nicorandil; SG-75) and its derivative on smooth muscle cells of the canine mesenteric artery.
    T Inoue, Y Kanmura, K Fujisawa, T Itoh and H Kuriyama
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 793-802;
  • You have access
    No evidence for involvement of endogenous opioid peptides in effects of clonidine on blood pressure, heart rate and plasma norepinephrine in anesthetized rats.
    E L Conway, M J Brown and C T Dollery
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 803-808;
  • You have access
    Absorption of diazepam and its transfer through the blood-brain barrier after intraperitoneal administration in the rat.
    T Hironaka, K Fuchino and T Fujii
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 809-815;
  • You have access
    Vasoconstrictor response induced by 5-hydroxytryptamine released from vascular adrenergic nerves by periarterial nerve stimulation.
    H Kawasaki and K Takasaki
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 816-822;
  • You have access
    Heterogeneity of smooth muscle alpha adrenoceptors in rat tail artery in vitro.
    I C Medgett and S Z Langer
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 823-830;
  • You have access
    Pharmacological characterization of the postsynaptic alpha adrenoceptors in vascular smooth muscle from canine and rat mesenteric vascular beds.
    D K Agrawal, C R Triggle and E E Daniel
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 831-838;
  • You have access
    Effects of chemical sympathectomy on insulin receptors and insulin action in isolated rat adipocytes.
    H G Joost and S H Quentin
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 839-844;
  • You have access
    Mechanism for isaxonine hepatitis. I. Metabolic activation by mouse and human cytochrome P-450.
    P Lettéron, H Fouin-Fortunet, M Tinel, G Danan, J Belghiti and D Pessayre
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 845-850;
  • You have access
    Mechanism for isaxonine hepatitis. II. Protective role of glutathione and toxicological studies in mice.
    H Fouin-Fortunet, P Lettéron, M Tinel, C Degott, J F Flejou and D Pessayre
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 851-858;
  • You have access
    Microiontophoretic studies of the dopaminergic inhibition from the ventral tegmental area to the nucleus accumbens neurons.
    A Akaike, M Sasa and S Takaori
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 859-864;
  • You have access
    Differences in d-[3H]lysergic acid diethylamide binding in mouse cortex and hippocampus in vivo and in vitro revealed by radioautography and rapid filtration studies.
    B J Ebersole, H Weinstein and S Maayani
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 865-871;
  • You have access
    Myosin isoenzyme expression in rat ventricle: effects of thyroid hormone analogs, catecholamines, glucocorticoids and high carbohydrate diet.
    D Sheer and E Morkin
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 872-879;
  • You have access
    Relationship between developmental changes in angiotensin II-induced contractions and stimulation of phosphatidylinositol labeling of rat aorta.
    D D Schoepp and C O Rutledge
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 880-886;
  • You have access
    Relation between alpha adrenergic receptor occupation and contractile response: radioligand and physiologic studies in canine aorta.
    A Sastre, K K Griendling, M M Rusher and W R Milnor
    Journal of Pharmacology and Experimental Therapeutics June 1984, 229 (3) 887-896;
Back to top
PreviousNext

In this issue

Journal of Pharmacology and Experimental Therapeutics
Vol. 229, Issue 3
1 Jun 1984
  • Table of Contents
  • Table of Contents (PDF)
  • Index by author
  • Back Matter (PDF)
  • Editorial Board (PDF)
  • Front Matter (PDF)
Sign up for alerts
  • Most Read
Loading
  • Smoking Could Worsen COVID-19 Outcome
  • KBP-042 as Adjunct Therapy to Metformin
  • SARS-CoV-2 Drug Discovery
  • Potential Clinical Uses of CBG
  • Nose-to-Brain Delivery
More...
  • Home
  • Alerts
Facebook   Twitter   LinkedIn   RSS

Navigate

  • Current Issue
  • Fast Forward by date
  • Fast Forward by section
  • Latest Articles
  • Archive
  • Search for Articles
  • Feedback
  • ASPET

More Information

  • About JPET
  • Editorial Board
  • Instructions to Authors
  • Submit a Manuscript
  • Customized Alerts
  • RSS Feeds
  • Subscriptions
  • Permissions
  • Terms & Conditions of Use

ASPET's Other Journals

  • Drug Metabolism and Disposition
  • Molecular Pharmacology
  • Pharmacological Reviews
  • Pharmacology Research & Perspectives
ISSN 1521-0103 (Online)

Copyright © 2021 by the American Society for Pharmacology and Experimental Therapeutics